beta-alanine has been researched along with Arterial Occlusive Diseases in 4 studies
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This article reports an acute ischemic stroke after cardioversion and atrial flutter catheter ablation in a patient on treatment by dabigatran 110mg twice daily." | 7.79 | [Ischemic stroke after cardioversion and atrial flutter ablation in a patient taking dabigatran]. ( Amara, W; Guedeney, P; Iusuf, A, 2013) |
| "This article reports an acute ischemic stroke after cardioversion and atrial flutter catheter ablation in a patient on treatment by dabigatran 110mg twice daily." | 3.79 | [Ischemic stroke after cardioversion and atrial flutter ablation in a patient taking dabigatran]. ( Amara, W; Guedeney, P; Iusuf, A, 2013) |
| "Dabigatran is a reversible, direct thrombin inhibitor, which is administered as dabigatran etexilate, the oral prodrug." | 2.48 | New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders. ( Dahl, OE, 2012) |
| "Dabigatran was stopped and dalteparin 5000 International Units/bid and 40 μg alprostadil infusions were started." | 1.38 | Fatal basilar artery occlusion under dabigatran occurring 13 days after femoral embolectomy. ( Finsterer, J; Reiter, M; Schäffl-Doweik, L; Stöllberger, C, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amara, W | 1 |
| Guedeney, P | 1 |
| Iusuf, A | 1 |
| Sheffield, WP | 1 |
| Lambourne, MD | 1 |
| Eltringham-Smith, LJ | 1 |
| Bhakta, V | 1 |
| Arnold, DM | 1 |
| Crowther, MA | 1 |
| Dahl, OE | 1 |
| Stöllberger, C | 1 |
| Reiter, M | 1 |
| Schäffl-Doweik, L | 1 |
| Finsterer, J | 1 |
1 review available for beta-alanine and Arterial Occlusive Diseases
| Article | Year |
|---|---|
New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders.
Topics: Administration, Oral; Animals; Antithrombins; Arterial Occlusive Diseases; Benzimidazoles; beta-Alan | 2012 |
3 other studies available for beta-alanine and Arterial Occlusive Diseases
| Article | Year |
|---|---|
[Ischemic stroke after cardioversion and atrial flutter ablation in a patient taking dabigatran].
Topics: Aged; Anticoagulants; Arterial Occlusive Diseases; Atrial Flutter; Benzimidazoles; beta-Alanine; Cat | 2013 |
γT -S195A thrombin reduces the anticoagulant effects of dabigatran in vitro and in vivo.
Topics: Animals; Anticoagulants; Arterial Occlusive Diseases; Benzimidazoles; beta-Alanine; Bleeding Time; B | 2014 |
Fatal basilar artery occlusion under dabigatran occurring 13 days after femoral embolectomy.
Topics: Aged; Anticoagulants; Antithrombins; Arterial Occlusive Diseases; Atrial Fibrillation; Benzimidazole | 2012 |